stage iiia melanoma
Showing 1 - 13 of 13
Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)
Completed
- Melanoma
- +4 more
- therapeutic conventional surgery
- +3 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center
Dec 30, 2020
Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (aldesleukin, ipilimumab, laboratory
Completed
- Recurrent Melanoma
- +4 more
- aldesleukin
- +2 more
-
Maywood, Illinois
- +4 more
Jun 17, 2020
Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (other, drug, procedure)
Completed
- Recurrent Melanoma
- +4 more
- cytology specimen collection procedure
- +4 more
-
Scottsdale, Arizona
- +7 more
Dec 16, 2019
Recurrent Melanoma, Stage IIA Melanoma, Stage IIB Melanoma Trial in Rochester (drug, biological, other)
Completed
- Recurrent Melanoma
- +7 more
- Montanide ISA 51 VG
- +4 more
-
Rochester, MinnesotaMayo Clinic
Oct 4, 2018
Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected
Completed
- Recurrent Melanoma
- +11 more
- siRNA-transfected peripheral blood mononuclear cells APN401
- laboratory biomarker analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 2, 2018
Extraocular Extension Melanoma, Metastatic Intraocular Melanoma, Recurrent Intraocular Melanoma Trial in Buffalo (axitinib,
Terminated
- Extraocular Extension Melanoma
- +11 more
- axitinib
- laboratory biomarker analysis
-
Buffalo, New YorkRoswell Park Cancer Institute
May 8, 2018
Recurrent Melanoma, Stage IIB Melanoma (Locally Advanced), Stage IIC Melanoma (Locally Advanced) Trial in Nashville (dabrafenib,
Terminated
- Recurrent Melanoma
- +6 more
- dabrafenib
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jun 20, 2017
Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in Nashville (diagnostic test, other, device)
Terminated
- Recurrent Melanoma
- +4 more
- [18F]fluorodeoxyglucose
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Apr 12, 2017
Recurrent Melanoma, Stage IA Melanoma, Stage IB Melanoma Trial in Portland (HPV 16 E7:12-20, gp100:209-217(210M), laboratory
Completed
- Recurrent Melanoma
- +8 more
- HPV 16 E7:12-20
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Dec 28, 2016
Acral Lentiginous Malignant Melanoma, Recurrent Melanoma, Stage IIIA Melanoma Trial in United States (imatinib mesylate,
Completed
- Acral Lentiginous Malignant Melanoma
- +5 more
- imatinib mesylate
- laboratory biomarker analysis
-
Los Angeles, California
- +7 more
Dec 15, 2014
Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in Atlanta, Boston, Richmond (cabozantinib-s-malate,
Terminated
- Recurrent Melanoma
- +5 more
- cabozantinib-s-malate
- +3 more
-
Atlanta, Georgia
- +2 more
Sep 23, 2014
Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,
Terminated
- Recurrent Melanoma
- +4 more
- Akt inhibitor MK2206
- +2 more
-
Atlanta, Georgia
- +3 more
May 16, 2014
Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in New Haven, Minneapolis (dasatinib)
Completed
- Recurrent Melanoma
- +4 more
-
New Haven, Connecticut
- +1 more
Apr 29, 2014